Netter HJ - Search Results

1

Modulation of the immunogenicity of virus-like particles composed of mutant hepatitis B virus envelope subunits.

Cheong WS, Hyakumura M, Yuen L, Warner N, Locarnini S, Netter HJ. Cheong WS, et al. Among authors: netter hj. Antiviral Res. 2012 Feb;93(2):209-218. doi: 10.1016/j.antiviral.2011.11.011. Epub 2011 Nov 26. Antiviral Res. 2012. PMID: 22138713

2

Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine.

Netter HJ, Woo WP, Tindle R, Macfarlan RI, Gowans EJ. Netter HJ, et al. Vaccine. 2003 Jun 20;21(21-22):2692-7. doi: 10.1016/s0264-410x(03)00182-8. Vaccine. 2003. PMID: 12798605

3

Failure of the lamivudine-resistant rtM204I hepatitis B virus mutants to efficiently support hepatitis delta virus secretion.

Vietheer PT, Netter HJ, Sozzi T, Bartholomeusz A. Vietheer PT, et al. Among authors: netter hj. J Virol. 2005 May;79(10):6570-3. doi: 10.1128/JVI.79.10.6570-6573.2005. J Virol. 2005. PMID: 15858045 Free PMC article.

4

Does RNA interference provide new hope for control of chronic hepatitis B infection?

Wilson R, Purcell D, Netter HJ, Revill PA. Wilson R, et al. Among authors: netter hj. Antivir Ther. 2009;14(7):879-89. doi: 10.3851/IMP1424. Antivir Ther. 2009. PMID: 19918092 Review.

5

Hepatitis B virus-like particles access major histocompatibility class I and II antigen presentation pathways in primary dendritic cells.

Moffat JM, Cheong WS, Villadangos JA, Mintern JD, Netter HJ. Moffat JM, et al. Among authors: netter hj. Vaccine. 2013 Apr 26;31(18):2310-6. doi: 10.1016/j.vaccine.2013.02.042. Epub 2013 Mar 7. Vaccine. 2013. PMID: 23473776

6

Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity.

Hyakumura M, Walsh R, Thaysen-Andersen M, Kingston NJ, La M, Lu L, Lovrecz G, Packer NH, Locarnini S, Netter HJ. Hyakumura M, et al. Among authors: netter hj. J Virol. 2015 Nov;89(22):11312-22. doi: 10.1128/JVI.01123-15. Epub 2015 Sep 2. J Virol. 2015. PMID: 26339047 Free PMC article.

7

The non-pathogenic Henipavirus Cedar paramyxovirus phosphoprotein has a compromised ability to target STAT1 and STAT2.

Lieu KG, Marsh GA, Wang LF, Netter HJ. Lieu KG, et al. Among authors: netter hj. Antiviral Res. 2015 Dec;124:69-76. doi: 10.1016/j.antiviral.2015.09.017. Epub 2015 Oct 23. Antiviral Res. 2015. PMID: 26526590

8

A Divergent Hepatitis D-Like Agent in Birds.

Wille M, Netter HJ, Littlejohn M, Yuen L, Shi M, Eden JS, Klaassen M, Holmes EC, Hurt AC. Wille M, et al. Among authors: netter hj. Viruses. 2018 Dec 17;10(12):720. doi: 10.3390/v10120720. Viruses. 2018. PMID: 30562970 Free PMC article.

9

Hepatitis B virus-like particles expressing Plasmodium falciparum epitopes induce complement-fixing antibodies against the circumsporozoite protein.

Kingston NJ, Kurtovic L, Walsh R, Joe C, Lovrecz G, Locarnini S, Beeson JG, Netter HJ. Kingston NJ, et al. Among authors: netter hj. Vaccine. 2019 Mar 14;37(12):1674-1684. doi: 10.1016/j.vaccine.2019.01.056. Epub 2019 Feb 14. Vaccine. 2019. PMID: 30773400

10

Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity.

Joe CCD, Chatterjee S, Lovrecz G, Adams TE, Thaysen-Andersen M, Walsh R, Locarnini SA, Smooker P, Netter HJ. Joe CCD, et al. Among authors: netter hj. Vaccine. 2020 May 8;38(22):3892-3901. doi: 10.1016/j.vaccine.2020.03.007. Epub 2020 Apr 10. Vaccine. 2020. PMID: 32284273

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters